๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Induction chemotherapy followed by concomitant chemoradiation-induced regression of advanced cervical lymphadenopathy in head and neck cancer as a predictor of outcome

โœ Scribed by Federico L. Ampil; Glenn M. Mills; Gloria Caldito; Gary V. Burton; Cherie Ann O. Nathan; Robert F. Aarstad; Timothy F. Lian; Fred J. Stucker; John C. Hardi Jr


Book ID
117843899
Publisher
SAGE Publications
Year
2002
Tongue
English
Weight
54 KB
Volume
126
Category
Article
ISSN
0194-5998

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Cost utility of docetaxel as induction c
โœ Anju Parthan; Marshall R. Posner; Caroline Brammer; Philippe Beltran; Jeroen P. ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 177 KB ๐Ÿ‘ 1 views

## Abstract ## Background Trial TAX 324 showed that induction chemotherapy with docetaxel plus cisplatin and 5โ€fluorouracil (TPF) compared with cisplatin and 5โ€fluorouracil (PF) followed by chemoradiation increases survival and time to progression in squamous cell carcinoma of head and neck (SCCHN